Iran Dismisses U.S. Peace Plan

Plus: President Trump plans to name some of the biggest names in business to a tech advisory panel. And drugmaker Merck acquires Terns Pharmaceutical for $6 billion to gain access to a promising cancer treatment. Alex Ossola hosts.

Sign up for WSJ’s free What’s News newsletter.

An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.